Literature DB >> 9485371

Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers.

Y R Hsu1, W C Chang, E A Mendiaz, S Hara, D T Chow, M B Mann, K E Langley, H S Lu.   

Abstract

During in vitro aging, deamidation of recombinant human stem cell factor produced in Escherichia. coli was detected by HPLC analysis and by the release of soluble ammonia. The deamidation rate is very slow in buffers at low pH or at low temperatures; however, the rate is significantly accelerated in alkaline buffers such as sodium bicarbonate in combination with elevated temperatures. HPLC isolation of various deamidated forms followed by peptide mapping and mass spectrometric analyses revealed that the deamidation involves Asn10 in the sequence -T9NNV- near the N-terminus of the protein. Following peptide mapping analysis, significant amounts of aspartyl and isoaspartyl peptides were identified, indicating the conversion of asparagine into both aspartate and isoaspartate residues. As a result of spontaneous association-dissociation of stem cell factor dimer, a total of five deamidated forms, including two homodimers and three heterodimers, were detected and isolated. Cell proliferation assays showed that two rhSCF heterodimeric species, derived from dimerization between isoaspartyl and other stem cell factor monomers, retain only approximately half of the biological activity. The homodimer with isoaspartic acid in place of Asn10 is 50-fold less potent, while the aspartyl homodimer, either isolated during deamidation experiments or recombinantly prepared by site-directed mutagenesis (e.g., N10D and N10D/N11D variants), exhibits higher activity than the standard molecule. In comparison, synthetic N10A and N10E variants, though missing the deamidation site, are significantly less active. All these variants lacking the Asn10 deamidation site are relatively more stable than those containing the asparagine residue. The results indicate that the biological function and chemical stability of stem cell factor are influenced by the nature of the residue at position 10.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485371     DOI: 10.1021/bi972372z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Quantitating the relative abundance of isoaspartyl residues in deamidated proteins by electron capture dissociation.

Authors:  Jason J Cournoyer; Cheng Lin; Michael J Bowman; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2006-09-25       Impact factor: 3.109

2.  Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases.

Authors:  Heli Liu; Xiaoyan Chen; Pamela J Focia; Xiaolin He
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

Review 3.  Proteomics Research in Cardiovascular Medicine and Biomarker Discovery.

Authors:  Maggie P Y Lam; Peipei Ping; Elizabeth Murphy
Journal:  J Am Coll Cardiol       Date:  2016-12-27       Impact factor: 24.094

4.  Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.

Authors:  X Jiang; O Gurel; E A Mendiaz; G W Stearns; C L Clogston; H S Lu; T D Osslund; R S Syed; K E Langley; W A Hendrickson
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

5.  Electron transfer dissociation with supplemental activation to differentiate aspartic and isoaspartic residues in doubly charged peptide cations.

Authors:  Wai Yi Kelly Chan; T W Dominic Chan; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2010-02-08       Impact factor: 3.109

6.  Characterization of asparagine deamidation and aspartate isomerization in recombinant human interleukin-11.

Authors:  Wei Zhang; J Marta J Czupryn; Philip T Boyle; John Amari
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

Review 7.  Post-translational modifications of recombinant proteins: significance for biopharmaceuticals.

Authors:  Nigel Jenkins; Lisa Murphy; Ray Tyther
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

8.  Skipping of exons by premature termination of transcription and alternative splicing within intron-5 of the sheep SCF gene: a novel splice variant.

Authors:  Siva Arumugam Saravanaperumal; Dario Pediconi; Carlo Renieri; Antonietta La Terza
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.